Zhangzhou Pientzehuang Pharmaceutical., Ltd

XSSC:600436 Stock Report

Market Cap: CN¥153.5b

Zhangzhou Pientzehuang Pharmaceutical Past Earnings Performance

Past criteria checks 4/6

Zhangzhou Pientzehuang Pharmaceutical has been growing earnings at an average annual rate of 16.4%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 13.6% per year. Zhangzhou Pientzehuang Pharmaceutical's return on equity is 21.3%, and it has net margins of 28.2%.

Key information

16.4%

Earnings growth rate

16.4%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate13.6%
Return on equity21.3%
Net Margin28.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Zhangzhou Pientzehuang Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:600436 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2410,9093,0791,095197
30 Jun 2410,6642,9781,142232
31 Mar 2410,6003,0021,166228
31 Dec 2310,0582,7971,162232
30 Sep 239,6782,825857267
30 Jun 239,3172,699779236
31 Mar 238,9752,553797245
31 Dec 228,6942,472808230
30 Sep 228,5262,473878245
30 Jun 228,5952,631941249
31 Mar 228,3682,5561,024256
31 Dec 218,0222,4321,034200
30 Sep 217,5532,354955103
30 Jun 217,1131,9221,061104
31 Mar 216,7981,7691,00189
31 Dec 206,5111,67298498
30 Sep 206,4511,5941,017126
30 Jun 206,0741,493901122
31 Mar 205,9521,438865132
31 Dec 195,7221,374799119
30 Sep 195,5221,332712141
30 Jun 195,2571,272659125
31 Mar 195,0281,221645108
31 Dec 184,7661,143629101
30 Sep 184,5551,05268574
30 Jun 184,36599165998
31 Mar 184,07690764782
31 Dec 173,71480761170
30 Sep 173,42873056441
30 Jun 173,1016645710
31 Mar 172,7006165200
31 Dec 162,3095364890
30 Sep 162,1805754260
30 Jun 162,0325203950
31 Mar 161,9754973630
31 Dec 151,8864673390
30 Sep 151,6985133000
30 Jun 151,5034742800
31 Mar 151,4554402690
31 Dec 141,4544392620
30 Sep 141,4093732750
30 Jun 141,4464222630
31 Mar 141,4364382520
31 Dec 131,3964302410

Quality Earnings: 600436 has high quality earnings.

Growing Profit Margin: 600436's current net profit margins (28.2%) are lower than last year (29.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 600436's earnings have grown by 16.4% per year over the past 5 years.

Accelerating Growth: 600436's earnings growth over the past year (9%) is below its 5-year average (16.4% per year).

Earnings vs Industry: 600436 earnings growth over the past year (9%) exceeded the Pharmaceuticals industry -2.5%.


Return on Equity

High ROE: 600436's Return on Equity (21.3%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies